Hrt Financial LP Amneal Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$5.24 - $6.34 $1.08 Million - $1.31 Million	206,012 New	206,012 $1.25 Million
Q1 2023 May 12, 2023	SELL	$1.27 - $2.7 $67,999 - $144,566	-53,543 Reduced 81.93%	11,811 $16,000
Q4 2022 Feb 10, 2023	BUY	$1.96 - $2.61 $128,093 - $170,573	65,354 New	65,354 $130,000
Q2 2022 Aug 12, 2022	BUY	$3.01 - $4.46 $788,367 - $1.17 Million	261,916 New	261,916 $832,000
Q1 2022 May 16, 2022	SELL	$3.9 - $4.89 $250,177 - $313,683	-64,148 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.95 - $5.85 $103,549 - $153,357	26,215 Added 69.11%	64,148 $307,000
Q3 2021 Nov 15, 2021	BUY	$4.31 - $5.64 $163,491 - $213,942	37,933 New	37,933 $202,000
Q1 2021 May 17, 2021	SELL	$4.74 - $7.38 $184,324 - $286,986	-38,887 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.95 - $5.42 $53,305 - $73,142	13,495 Added 53.15%	38,887 $177,000
Q3 2020 Nov 13, 2020	SELL	$3.54 - $5.27 $71,900 - $107,038	-20,311 Reduced 44.44%	25,392 $98,000
Q2 2020 Aug 14, 2020	BUY	$2.87 - $5.46 $131,167 - $249,538	45,703 New	45,703 $217,000

186

137M

234K

45.9K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.24B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.